Standard methods were available for selectively growing cells with functional HPRT enzymes and had already been used for several years for selection of mutants, hybridoma cells in monoclonal antibody production etc. ❋ Unknown (2007)
The principle features of the hybridoma technology is as follows (Figure 2). ❋ Unknown (1984)
The product of this fusion is referred to as a hybridoma. ❋ Unknown (1984)
In all, it is therefore correct to describe the hybridoma technique discovered by Georges Köhler and César Milstein as one of the major methodological advances in medicine during this century. ❋ Unknown (1984)
Besides gene technology, which has already been honoured by several Nobel Prizes, the hybridoma technique represents the most important methodological advance within the field of biomedicine during the 1970s. ❋ Unknown (1984)
By special arrangements it is possible to achieve a multiplication of hybridoma cells but not of isolated myeloma cells. ❋ Unknown (1984)
César Milstein in 1975 introduced the so-called hybridoma technology for production of monclonal antibodies. ❋ Unknown (1984)
Milstein described the hybridoma technique for production of monoclonal antibodies. ❋ Unknown (1984)
Köhler's, and Milstein's development of the hybridoma technique for production of monoclonal antibodies have in less than ❋ Unknown (1984)
The hybridoma technique for the production of monoclonal antibodies represents one of the most important methodological advances in biomedicine during the 1970s. ❋ Unknown (1984)
The discovery and development of principles for production of the so-called monoclonal antibodies by the hybridoma technique by Georges Köhler and César ❋ Unknown (1984)
The precision in diagnosis is greatly improved, and entirely new possibilities for therapy have been opened up via the hybridoma technique. ❋ Unknown (1984)
The hybridoma cells can be stored in tissue banks and the very same monoclonal antibody can be used all over the world with a guarantee for eternal supply. ❋ Unknown (1984)
Köhler and Milstein called these hybrid cells hybridomas, and as all cells in a given hybridoma come from one single hybrid cell, the antibodies made are monoclonal. ❋ Unknown (1984)
A particular hybridoma can then be used for future, unlimited production of a highly specific antibody. ❋ Unknown (1984)
Previous work by the company showed how 20 hybridoma supernatants could be rapidly screened and ranked against the cell signalling gene human interleukin 9 (IL-9). ❋ Unknown (2010)
Besides Neowater's inert nature, which does not interfere with biochemical processes, Do-Coop has demonstrated in various studies that Neowater can enhance hybridoma formation, cell proliferation, clonability and secretion of biotherapeutics. ❋ Unknown (2010)
- As a core member of the Immune Protein Screening team, this individual will develop assays, generate antibodies using state-of-the-art hybridoma technologies, and screen and characterize antibodies ❋ Unknown (2010)
For example, the monoclonal antibodies to be used in accordance with the present invention may be made by the hybridoma method first described by Kohler et al., ❋ Unknown (2010)
Fixed cells were stained with undiluted 5. 1H11 hybridoma supernatant against the human muscle-specific cell surface antigen ❋ Katarina Hajdin Et Al. (2010)
